Phacilitate Leaders Forum

Sponsors & Exhibitors

apceth Biopharma GmbH

Bronze Sponsor

apceth's vision is to improve patients’ lives with next generation cell therapies. Our programs aim to bring transformative and curative drugs to the patients.

apceth-201 are genetically modified MSCs which expresses Alpha-1 Antitrypsin for the treatment of GvHD, IBD, COPD and diabetes.

apceth-301 are MSCs that expresses a cocktail of cytokines which locally activates the immune system to eradicate tumor cells. apceth-301 is being developed for solid tumors.

We are also a leader in GMP manufacturing of cell-based therapies offering cutting-edge expertise and capabilities. Our unique and comprehensive quality management system has allowed us to successfully obtained manufacturing licenses for multiple cell therapy products. Our facilities are located in Munich, Germany.

Visit Website
View all Sponsors & Exhibitors
Loading
Testimonials
  • Real thinking forward combining experts in the field from manufacturing, regulatory and value vision” – “great network with strong experience and sharing risks & opportunities
    Jean-Philippe Combal
    GenSight Biologics
  • The conference consistently proves to be a great forum for networking with industry leaders in the development of cellular and gene therapies as well as vendors for important technologies and services.
    Michael Covington
    Juno Therapeutics, Inc
  • It was a very interesting event as all participants, including speakers were ready to exchange, even on the most challenging subjects such as reimbursement, GMP guidance
    Bertrand Alexandre
    Celyad
  • Phacilitate EU delivered it's promise and more, the topics discussed were highly relevant, with very good and professional speakers and panelists. You will see me next year in Berlin.
    Dr Ohad Karnieli
    Karnieli Ltd